Emerging therapies for treatment of multiple sclerosis

por Corboy, John R, Miravalle, Augusto A
Publicado 2010

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

por Piquet, Amanda L., Corboy, John R., Vollmer, Timothy L.
Publicado 2021

Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells

por Hassani, Asma, Corboy, John R., Al-Salam, Suhail, Khan, Gulfaraz
Publicado 2018

Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis

por Vollmer, Brandi L., Wolf, Andrew B., Sillau, Stefan, Corboy, John R., Alvarez, Enrique
Publicado 2022

Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment

por Vollmer, Brandi L., Nair, Kavita, Sillau, Stefan, Corboy, John R., Vollmer, Timothy, Alvarez, Enrique
Publicado 2020

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment

por Vollmer, Brandi L., Nair, Kavita V., Sillau, Stefan, Corboy, John R., Vollmer, Timothy, Alvarez, Enrique
Publicado 2018

Serious safety events in rituximab‐treated multiple sclerosis and related disorders

por Vollmer, Brandi L., Wallach, Asya I., Corboy, John R., Dubovskaya, Karolina, Alvarez, Enrique, Kister, Ilya
Publicado 2020

Adjustments in Torque Steadiness During Fatiguing Contractions Are Inversely Correlated With IQ in Persons With Multiple Sclerosis

por Gould, Jeffrey R., Reineberg, Andrew E., Cleland, Brice T., Knoblauch, Kristi E., Clinton, Grace K., Banich, Marie T., Corboy, John R., Enoka, Roger M.
Publicado 2018

Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate

por Honce, Justin M., Nair, Kavita V., Hoyt, Brian D., Seale, Rebecca A., Sillau, Stefan, Engebretson, Eric, Schurr, Brittany, Corboy, John R., Vollmer, Timothy L., Alvarez, Enrique
Publicado 2020

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers

por Vollmer, Brandi, Ontaneda, Daniel, Bandyopadhyay, Anasua, Cohn, Sam, Nair, Kavita, Sillau, Stefan, Bermel, Robert A., Corboy, John R., Fox, Robert J., Vollmer, Timothy, Cohen, Jeffrey A., Alvarez, Enrique, Hersh, Carrie M.
Publicado 2018

TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury

por Shafit-Zagardo, Bridget, Sidoli, Simone, Goldman, James E., DuBois, Juwen C., Corboy, John R., Strittmatter, Stephen M., Guzik, Hillary, Edema, Ukuemi, Arackal, Anita G., Botbol, Yair M., Merheb, Emilio, Nagra, Rashed M., Graff, Sarah
Publicado 2023

Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

por Cree, Bruce A. C., Goldman, Myla D., Corboy, John R., Singer, Barry A., Fox, Edward J., Arnold, Douglas L., Ford, Corey, Weinstock-Guttman, Bianca, Bar-Or, Amit, Mientus, Susanne, Sienkiewicz, Daniel, Zhang, Ying, Karan, Rajesh, Tenenbaum, Nadia
Publicado 2021

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis

por Barrera, Britney, Simpson, Haley, Engebretson, Eric, Sillau, Stefan, Valdez, Brooke, Parra‐González, José, Winger, Ryan C., Epperson, Lou Anne, Banks, Ashley, Pierce, Kathryn, Spotts, Melanie, O'Gean, Katie, Alvarez, Enrique, Gross, Robert, Piquet, Amanda L., Schreiner, Teri, Corboy, John R., Pei, Jinglan, Vollmer, Timothy L., Nair, Kavita V.
Publicado 2023